|
|
|
|
|
|
|
|
|
|
Rv0667 More about Rv0667 on TBDB.org More about Rv0667 on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv0667: all mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Heep M AAC 2000 | GTC/TTC | - | 146 | Val/Phe | Published 2003 | Japan | Sequencing | Whole gene | R | 1-4, 8-32 ug/ml | N.S. | (6/6 || 3 high level of resistance / 6 total) | (3/0) | - | - |
| Taniguchi H FEMS Micro 1996 | GCG/GTG | - | 381 | Ala/Val | Published 1997 | Japan | Sequencing | Whole gene | R | 200 ug/ml | Proportion method, absolute concentration method | 21/39 | (1/0) | - | - |
| Cavusoglu C JCM 2002 | CAG/CAT | - | 490 | Gln/His | Published 2002 | Turkey | Line probe assay, Sequencing | RRDR | R, RE, RHE, RH, RHES, RHS | N.S. | Proportion method | 41/41 | (1/0) | - | - |
| Schilke K IntJTubLungDis 1999 | GAG/GCG | - | 504 | Glu/Ala | Published 1999 | South Africa | Sequencing | RRDR | MDR | N.S. | Not specified | 105/105 | (2/0) | Double mutation with 531 | - |
| Heym B Lancet 1994 | TTC/TTG | - | 505 | Phe /Leu | 1991-1992 | La Reunion | PCR-SSCP | - | RSHE | > 100 mg/L | Proportion method | 13/39 | (2/0) | "1) rpoB L511P; S531C; rpsL K42R; katG no mutation; inhA mutation present 2) rpoB L511P; S531C; rpsL K42R; katG mutation present; inhA mutation present" | - |
| Stavrum R PlosOne 2009 | TTC/TTA | - | 505 | Phe /Leu | Published 2009 | India | Sequencing | Whole gene | RSHE | > 100 mg/L | Proportion method | 13/39 | (2/0) | "1) rpoB L511P; S531C; rpsL K42R; katG no mutation; inhA mutation present 2) rpoB L511P; S531C; rpsL K42R; katG mutation present; inhA mutation present" | - |
| Wang Q JProtRes 2007 | TTC/TCC | - | 505 | Phe/Ser | Published 1997 | China | Sequencing | Whole gene | R | N.S. | Proportion method, absolute concentration method | 112/30 | 1/0 | - | - |
| Bahrmand AR JCM 2009 | GGC/AGC | - | 507 | Gly/Ser | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | <50 ug/ml | Proportion method | 41/286 | 1/0 | rpoB T508P | - |
| Kim BJ JCM 1997 | GGC/GAC | - | 507 | Gly/Asp | Published 1997 | South Korea | PCR-SSCP, Sequencing | RRDR | R | N.S. | Absolute concentration method. | 32/58 | 1/0 | Location of double mutants not specified. | - |
| Bahrmand AR JCM 2009 | GGC/GAT | - | 507 | Gly/Asp | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | >100 ug/ml | Proportion method | 41/286 | 2/0 | rpoB Q513STOP, H526Y, S531F | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | del GGC ACC | - | 507-508 | del Gly Thr | - | - | - | - | - | - | - | - | - | - | - |
| Bahrmand AR JCM 2009 | ACC/CAC | - | 508 | Thr/His | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | >100 ug/ml | Proportion method | 41/286 | 6/0 | rpoB H526Q, S531F | - |
| Bahrmand AR JCM 2009 | ACC/CCC | - | 508 | Thr/Pro | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | <50 ug/ml | Proportion method | 41/286 | 4/0 | rpoB G507S | - |
| Bahrmand AR JCM 2009 | ACC/GCC | - | 508 | Thr/Ala | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | <75 ug/ml | Proportion method | 41/286 | 2/0 | rpoB G523A | - |
| Mani C JCM 2001 | ACC/AGC | - | 508 | Thr/Ser | Published 2001 | India | Sequencing | RRDR | R | >128ug/ml | Proportion method | 44/50 | 1/0 | None described in the region sequenced. | - |
| Matsiota-Bernard P JCM 1998 | ACC/GCT | - | 508 | Thr/Ser | 1995-1996 | Greece | Line probe assay, Sequencing | RRDR | RHSEth | N.S. | Proportion method | 17/17 | 1/0 | None described in the region sequenced. | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | AGC/CAG | - | 509 | Ser/Gln | 2007 | Mexico | Sequencing | RRDR | HRSEZ | N.S. | BACTEC 460 | 15/25 | 1/0 | None | - |
| Williams D AAC 1994 | AGC/ACC | - | 509 | Ser/Thr | Published 1994 | Canada | Sequencing | RRDR | RHES | N.S. | Proportion method | 108/120 | (1/0) | Double mutation with 526 (Asp) | - |
| Sekiguchi J JCM 2007 Jan | AGC/AGG | - | 509 | Ser/Arg | Published 2007 | Japan | Sequencing | RRDR | R, MDR | N.S. | Proportion method, BACTEC | 28/138 | (0/1) | - | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | CAG/AAG | - | 510 | Gln/Lys | 2007 | Mexico | Sequencing | RRDR | HREZ | N.S. | BACTEC 460 | 15/25 | 1/0 | None | - |
| Sajduda A JCM 2004 | CAG/CAC | - | 510 | Gln/His | 2000 | Poland | real-time sequencing FRET | RRDR | R, MDR | N.S. | BACTEC 460 | 64/113 | (2/0) | rpoB: double mutation with 516 GAC/TAC | - |
| Kapur V JCM 1994 | CTG/CCG | - | 511 | Leu/Pro | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 4/0 | "One of the strains was also Asp441Glu; another was Asp441Tyr; the third was also Ser437Thr." | ![]() |
| Kapur V JCM 1994 | CTG/CGG | - | 511 | Leu/Arg | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | None described in the region sequenced. | - |
| Siddiqi N AAC 2002 | CTG/GTG | - | 511 | Leu/Val | 1995-1998 | India | Sequencing | RRDR | R,O | Not listed in Table | Proportion method | 94/126 | (2/0) | "1) rpoB dual mutation with N518T; gyrA S95T; 2) gyrA S95T" | - |
| Kapur V JCM 1994 | AGC/ACC | - | 512 | Ser/Thr | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 1/0 | Also mutated at Leu436Pro. | - |
| Sajduda A JCM 2004 | AGC/ATC | - | 512 | Ser/Ile | 2001 | Poland | real-time sequencing FRET | RRDR | R, MDR | N.S. | BACTEC 460 | 64/113 | (1/0) | rpoB: double mutation with 516 GAC/GGC | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | AGC/CGC | - | 512 | Ser/Arg | - | - | - | - | - | - | - | - | - | - | - |
| Chan RCY JAC 2007 | AGC/GGC | - | 512 | Ser/Gly | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | RRDR | - | - | Absolute concentration method | 250 | 221 | - | - |
| Bahrmand AR JCM 2009 | CAA/TAA | - | 513 | Gln/STOP | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | >100 ug/ml | Proportion method | 41/286 | 2/0 | rpoB G507D, H526Y, S531F | - |
| Bahrmand AR JCM 2009 | CAA/AAT | - | 513 | Gly/Asn | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | >100 ug/ml | Proportion method | 41/286 | 2/0 | rpoB S512T, H526F, S531L | - |
| Kapur V JCM 1994 | CAA/CTA | - | 513 | Gln/Leu | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | None described in the region sequenced. | ![]() |
| Kapur V JCM 1994 | CAA/AAA | - | 513 | Gln/Lys | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 1/0 | None described in the region sequenced. | - |
| Prammananan T CMI 2008 | CAA/GAA | - | 513 | Gln/Glu | 2003-2005 | Thailand | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 154/113 | 1/0 | None described in the region sequenced. | - |
| Kim BJ JCM 1997 | CAA/CCA | - | 513 | Gln/Pro | Published 1997 | South Korea | Sequencing | RRDR | R | N.S. | Absolute concentration method. | 32/58 | 2/0 | Location of double mutants not specified. | - |
| Valim A JCM 2000 | CAA/CAC | - | 513 | Gln/His | - | - | - | - | - | - | - | 82/100 | 1/0 | - | - |
| Secondary Publication: O'Sullivan DM JAntiChemo 2005 | CAA/CGA | - | 513 | Gln/Arg | - | - | - | - | - | - | - | - | - | - | - |
| Kapur V JCM 1994 | ins TTC | - | 513-514 | ins Phe | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | None described in the region sequenced. | - |
| Kapur V JCM 1994 | ins TTC ATG | - | 513-514 | ins Phe Met | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 1/0 | None described in the region sequenced. | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | del CAA TTC | - | 513-514 | del Gln Phe | - | - | - | - | - | - | - | - | - | - | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | del AA TTC ATG G | - | 513-516 | Gln/His and del Phe Met | - | - | - | - | - | - | - | - | - | - | - |
| Valim A JCM 2000 | del TTC | - | 514 | del Phe | 1996-1998 | Brazil | Sequencing | RRDR | RHSZEth | N.S. | Proportion method | 82/100 | (1/0) | Same isolate had deletions: 515 (ATG-Met), 516(GAC-Asp) and change in codon 513 CAA(Gln)/CAC(His) | - |
| Taniguchi H FEMS Micro 1996 | TTC/TTG | - | 514 | Phe/Leu | Published 1996 | Japan | Sequencing | Whole gene | R | 12.5 ug/ml | Proportion method, absolute concentration method | 21/39 | (1/0) | - | - |
| Valim A JCM 2000 | TTC/GTC | - | 514 | Phe/Val | 1996-1998 | Brazil | Sequencing | RRDR | RHSZEth | N.S. | Proportion method | 82/100 | (1/0) | Same isolate had change in codon 531 TCG(Ser)/TTG(Leu) | - |
| Cavusoglu C JCM 2002 | ins CGG | - | 514-515 | ins Arg | Published 2002 | Turkey | Line probe assay, Sequencing | RRDR | R, RE, RHE, RH, RHES, RHS | N.S. | Proportion method | 41/41 | (1/0) | - | - |
| Lipin MY CMI 2007 | del C AT | - | 514-515 | Phe/Leu and del Met | 1998-2001 | Russia | Sequencing | RRDR | RHS, RHSK, RHSE | N.S. | Absolute concentration method. | 217/217 | 1/0 | None described in the region sequenced. | - |
| Valim A JCM 2000 | del TTC ATG GAC | - | 514-516 | del Phe Met Asp | 1996-1998 | Brazil | Sequencing | RRDR | RHSZEth | N.S. | Proportion method | 82/100 | (1/0) | Same isolate had change in codon 513 CAA(Gln)/CAC(His) | - |
| Hillemann D Int J Tuberc Lung Dis 2005 | ins TTC | - | 515 | ins Phe | 2004 | Kazakhstan, Germany | real-time sequencing FRET | RRDR | MDR | N.S. | N.S. | 92/152 | (1/0) | - | - |
| Sajduda A JCM 2004 | ATG/ATT | - | 515 | Met/Ile | 2003 | Poland | real-time sequencing FRET | RRDR | R, MDR | N.S. | BACTEC 460 | 64/113 | (8/0) | rpoB: double mutation with 516 GAC/TAC | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | ATG/ATA | - | 515 | Met/Ile | - | - | - | - | - | - | - | - | - | - | - |
| Valim A JCM 2000 | del ATG GAC CAG AAC | - | 515-518 | del Met Asp Gln Asn | 1996-1998 | Brazil | Sequencing | RRDR | RHSEZEth | N.S. | Proportion method | 82/100 | (1/0) | - | - |
| Schilke K IntJTubLungDis 1999 | GAC/AAC | - | 516 | Asp/Asn | Published 1999 | South Africa | Sequencing | RRDR | MDR | N.S. | N.S. | 105/105 | (1/0) | - | - |
| Bahrmand AR JCM 2009 | GAC/CAC | - | 516 | Asp/His | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | 50-75 ug/ml | Proportion method | 41/286 | 3/0 | rpoB D516H, H526R | - |
| Kapur V JCM 1994 | GAC/GTC | - | 516 | Asp/Val | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 1/0 | None described in the region sequenced. | ![]() |
| Kapur V JCM 1994 | GAC/GAG | - | 516 | Asp/Glu | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | Also mutated at Leu436Pro. | - |
| Hillemann D Int J Tuberc Lung Dis 2005 | GAC/GGC | - | 516 | Asp/Gly | 2004 | Kazakhstan, Germany | real-time sequencing FRET | RRDR | MDR | N.S. | N.S. | 92/152 | (1/0) | - | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | GAC/GCC | - | 516 | Asp/Ala | - | - | - | - | - | - | - | - | - | - | - |
| Sajduda A JCM 2004 | GAC/GTG | - | 516 | Asp/Val | 2004 | Poland | real-time sequencing FRET | RRDR | R, MDR | N.S. | BACTEC 460 | 64/113 | (1/0) | None | - |
| Kapur V JCM 1994 | GAC/TAC | - | 516 | Asp/Tyr | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | Also mutated at Leu436Pro. | ![]() |
| Hillemann D Int J Tuberc Lung Dis 2005 | GAC/TTC | - | 516 | Asp/Phe | 2004 | Kazakhstan, Germany | real-time sequencing FRET | RRDR | MDR | N.S. | N.S. | 92/152 | (1/0) | - | - |
| Kapur V JCM 1994 | del GAC CAG | - | 516-517 | del Asp Gln | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | None described in the region sequenced. | - |
| Xueqiong W MolBiotech 2009 | GAC/CAC | - | 517 | Gln/His | 2002-2005 | China | Sequencing | RRDR | RSE | N.S. | Absolute concentration method | 112/148 | 1/0 | rpoB N518D | - |
| Mani C JCM 2001 | del GAC | - | 517 | del Gln | Published 2001 | India | Sequencing | RRDR | R | >128ug/ml | Proportion method | 44/50 | 1/0 | None described in the region sequenced. | - |
| Sajduda A JCM 2004 | CAA/CTA | - | 517 | Gln/Leu | 2005 | Poland | real-time sequencing FRET | RRDR | R, MDR | N.S. | BACTEC 460 | 64/113 | (1/0) | None | - |
| Hillemann D AAC 2005 | del CAG AAC | - | 517-518 | del Gln Asn | 2001 | Germany | real-time sequencing | RRDR | MDR | N.S. | - | 103/113 | (1/0) | katG 315 AGC-ACC/Ser-Thr | - |
| Kapur V JCM 1994 | del CAG AAC | - | 517-518 | del Gln Asn | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 1/0 | None described in the region sequenced. | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | del G AAC AA | - | 517-519 | Gln/His and del Asn Asn | - | - | - | - | - | - | - | - | - | - | - |
| Wang Q JProtRes 2007 | AAC/TAC | - | 518 | Asn/Tyr | Published 1997 | China | Sequencing | Whole gene | R | N.S. | Proportion method, absolute concentration method | 112/30 | 1/0 | - | - |
| Siddiqi N AAC 2002 | AAC/ACC | - | 518 | Asn/Thr | 1995-1998 | India | Sequencing | RRDR | RHO, ROS, RO, RH | N.S. | Proportion method | 94/126 | (6/0) | "1) rpoB dual mutaton with L511L; katG and inhA NM; gyrA A90A, S95T 3) rpoB dual mutation with R528P; gyrA S95T; rpsL NM; 4) rpoB dual mutaton with L511V; gyrA S95T; 5) gyrA S95T; 6) gyrA NM; 7) rpoB dual mutation with D516V; katG and inhA R463L" | - |
| Hillemann D AAC 2005 | AAC/ATC | - | 518 | Asn/Ile | 2001 | Germany | real-time sequencing | RRDR | MDR | N.S. | - | 103/113 | (1/0) | None | - |
| Kim BJ JCM 1997 | AAC/CAC | - | 518 | Asn/His | Published 1997 | South Korea | Sequencing and PCR-SSCP | RRDR | R | N.S. | Absolute concentration method. | 32/58 | 1/0 | Location of double mutants not specified. | - |
| Chan RCY JAC 2007 | AAC/GAC | - | 518 | Asn/Asp | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | RRDR | - | - | Absolute concentration method. | 250 | 221 | - | - |
| Bahrmand AR JCM 2009 | AAC/AAG | - | 519 | Asn/Lys | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | 50 ug/ml | Proportion method | 41/286 | 2/0 | rpoB L511V, Q513E, H526R | - |
| Heym B Lancet 1994 | del AAC | - | 519 | del Asn | 1991-1992 | Russia, Netherlands | PCR-SSCP | - | MDR | 10-100ug/ml | Proportion method | 13/39 | (2/0) | "1) katG mutation present; inhA no mutation present; 2) katG no mutation present" | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | CTG/ATG | - | 521 | Leu/Met | - | - | - | - | - | - | - | - | - | - | - |
| Taniguchi H FEMS Micro 1996 | CTG/CCG | - | 521 | Leu/Pro | Published 1998 | Japan | Sequencing | Whole gene | R | < 0.39 ug/ml | Proportion method, absolute concentration method | 21/39 | (0/1) | - | - |
| Secondary Publication: O'Sullivan DM JAntiChemo 2005 | CTG/CTA | - | 521 | Leu/Leu | - | - | - | - | - | - | - | - | - | - | - |
| Bodmer T JAC 1995 | TCG/TTG | - | 522 | Ser/Leu | Published 1998 | N.S. | PCR-SSCP | RRDR | R | 8ug/ml | BACTEC 460 | 26/36 | (1/0) | - | ![]() |
| Yuen LK JCM 1999 | TCG/CAG | - | 522 | Ser/Gln | 1990-1997 | Timor | Sequencing | RRDR | RH | 32-256 ug/ml | Resistance ratio method, ,BACTEC 460, E-test | 33/50 | (2/0) | None | - |
| Secondary Publication: O'Sullivan DM JAntiChemo 2005 | TCG/TGG | - | 522 | Ser/Trp | - | - | - | - | - | - | - | - | - | - | - |
| El Baghdadi J IJTLD 2003 | CCC/ACC | - | 523 | Gly/Trp | 1996-2001 | Morocco | Sequencing | RRDR | RHS | N.S. | Resistance ratio method | 101/122 | (1/0) | - | - |
| Pozzi G JCM 1999 | GGG/TGG | - | 523 | Gly/Trp | Published April 2000 | Italy | Sequencing | RRDR | RH, RHS, RHSCip, RHSAmi, RHSZ, RHSZAmi, RHSCZ | 8-128ug/ml | Absolute concentration method | 37/37 | (1/0) | Triple mutation with GAC516TAC and ACC525ATC | - |
| Bahrmand AR JCM 2009 | GGG/GCG | - | 523 | Gly/Ala | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | >100 ug/ml | Proportion method | 41/286 | 25/0 | rpoB T508A or S531L or L511V, or H526R | - |
| Valim A JCM 2000 | TTG/TGG | - | 524 | Leu/Trp | 1996-1998 | Brazil | Sequencing | RRDR | MDR | N.S. | Proportion method | 82/100 | (1/0) | "Same isolate had changes in codons 525 ACC(Thr)/CCC(Pro); 526 CAC(His)/CTG(Leu); 527 del AAG(Lys)" | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | TTG/TCG | - | 524 | Leu/Ser | 2007 | Mexico | Sequencing | RRDR | HR | N.S. | BACTEC 460 | 15/25 | 1/0 | rpoB S531L | - |
| Valim A JCM 2000 | ACC/CCC | - | 525 | Thr/Pro | 1996-1998 | Brazil | Sequencing | RRDR | MDR | N.S. | Proportion method | 82/100 | (1/0) | "Same isolate had changes in codons 524 TTG(Leu)/TGG(Trp); 526 CAC(His)/CTG(Leu); 527 del AAG(Lys)" | - |
| Pozzi G JCM 1999 | ACC/ATC | - | 525 | Thr/Ile | Published April 2001 | Italy | Sequencing | RRDR | RH, RHS, RHSCip, RHSAmi, RHSZ, RHSZAmi, RHSCZ | 8-128ug/ml | Proportion method | 37/37 | (1/0) | Triple mutation with GAC516TAC and GGG523TGG | - |
| Bahrmand AR JCM 2009 | CAC/TTC | - | 526 | His/Phe | 2005-2006 | Iran | Sequencing | 411bp fragment of rpoB | 41R, 37MDR | >100 ug/ml | Proportion method | 41/286 | 2/0 | rpoB S512T, G513N, S531L | - |
| Ramaswamy SV J Med Micro 2004 | CAC/AAC | - | 526 | His/Asn | 1996-2001 | Mexico | Sequencing | - | RHSE | N.S. | Proportion method | 37/50 | (1/0) | "rpoB: Double mutation with 435 GAC/GAG; embB: 306 ATG/ATA1 " | ![]() |
| Kapur V JCM 1994 | CAC/GAC | - | 526 | His/Asp | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 8/0 | None described in the region sequenced. | ![]() |
| Kapur V JCM 1994 | CAC/TAC | - | 526 | His/Tyr | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 39/0 | None described in the region sequenced. | ![]() |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | CAC/ACC | - | 526 | His/Thr | - | - | - | - | - | - | - | - | - | - | - |
| Prammananan T CMI 2008 | CAC/AGC | - | 526 | His/Ser | 2003-2005 | Thailand | Sequencing | Whole gene | MDR | N.S. | Proportion method | 154/113 | 1/0 | rpoB 515 ATG/CTG | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | CAC/GGC | - | 526 | His/Gly | - | - | - | - | - | - | - | - | - | - | - |
| Kim BJ JCM 1997 | CAC/TGC | - | 526 | His/Cys | Published 1997 | South Korea | PCR-SSCP, Sequencing | RRDR | R | N.S. | Absolute concentration method. | 32/58 | 2/0 | Location of double mutants not specified. | - |
| Kim BJ JCM 1997 | CAC/CGC | - | 526 | His/Arg | Published 1997 | South Korea | PCR-SSCP, Sequencing | RRDR | R | N.S. | Absolute concentration method. | 32/58 | 1/0 | Location of double mutants not specified. | ![]() |
| Bodmer T JAC 1995 | CAC/CCC | - | 526 | His/Pro | Published 2001 | N.S. | PCR-SSCP | RRDR | R | 8ug/ml | BACTEC 460 | 26/36 | (2/0) | - | - |
| Valim A JCM 2000 | CAC/CTG | - | 526 | His/Leu | 1996-1998 | Brazil | Sequencing | RRDR | RHSEZEth | N.S. | Proportion method | 82/100 | (1/0) | "Same isolate had changes in codons 524 TTG(Leu)/TGG(Trp); 525 ACC(Thr)/CCC(Pro); 527 del AAG(Lys)" | - |
| Sheng J JApplMicro 2008 | CAC/CTT | - | 526 | His/Leu | 2002-2003 | China | PCR-SSCP , Sequencing | RRDR | R | N.S. | Agar proportion method | 49/56 | 1/0 | None in rpoB | - |
| Kapur V JCM 1994 | CAC/CTC | - | 526 | His/Leu | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 2/0 | None described in the region sequenced. | ![]() |
| Kapur V JCM 1994 | CAC/CAA | - | 526 | His/Gln | Published 1994 | USA | Sequencing | Whole gene | R | N.S. | Proportion method, BACTEC | 121/128 | 1/0 | Also mutated at Ser456Cys. | - |
| Bodmer T JAC 1995 | CAC/CAG | - | 526 | His/Gln | Published 2003 | N.S. | PCR-SSCP | RRDR | R | >8ug/ml | BACTEC 460 | 26/36 | (2/0) | Double mutation with 498 Val/Ala | - |
| Siddiqi N AAC 2002 | AAG/AAT | - | 527 | Lys/Asn | 1995-1998 | India | Sequencing | RRDR | HRH | 40 ug/ml | Proportion method | 94/126 | (2/0) | "1) katG or inhA R463L; 2) katG or inhA R463L, rpoB dual mutation with L521L" | - |
| Valim A JCM 2000 | del AAG | - | 527 | del Lys | 1996-1998 | Brazil | Sequencing | RRDR | RHSEZEth | N.S. | Proportion method | 82/100 | (1/0) | "Same isolate had changes in codons 524 TTG(Leu)/TGG(Trp); 525 ACC(Thr)/CCC(Pro); 526 CAC(His)/CTG(Leu)" | - |
| Williams D AAC 1994 | AAG/CAG | - | 527 | Lys/Gln | Published 1995 | USA | PCR-HDF, Sequencing | RRDR | RHEEt | N.S. | Proportion method | 108/120 | (1/0) | Double mutation with 526 (His) | - |
| Siddiqi N AAC 2002 | CGC/CAC | - | 528 | Arg/His | 1995-1998 | India | Sequencing | RRDR | HR, ROS | 64-128 ug/ml | Proportion method | 94/126 | (2/0) | "1) rpoB dual mutation with H526Y; gyrA S95T; rpsL NM; 2) rpoB 1 dual mutation with with S531W; katG and inhA R463L, Inh (C/T)" | - |
| Siddiqi N AAC 2002 | CGC/CCC | - | 528 | Arg/Pro | 1995-1998 | India | Sequencing | RRDR | ROS, RHO, RHS, RH | 40-64 ug/ml* | Proportion method | 94/126 | (4/0) | "1) rpoB dual mutation with N518T; gyrA S95T; rpsL NM; 2) katG or inhA NA; gyrA S95T; 3) katG or inhA R463L; rpsL K121K; 4) katG or inhA R463L; rpoB dual mutation with H526Y" | - |
| Zenteno-Cuevas R MemInstOswaldCruz 2009 | CGC/CCT | - | 528 | Arg/Pro | 2007 | Mexico | Sequencing | RRDR | HRSEZ | N.S. | BACTEC 460 | 15/25 | 1/0 | None | - |
| Wang Q JProtRes 2007 | TCG/TAG | - | 538 | Leu/STOP | Published 1997 | China | Sequencing | Whole gene | R | N.S. | Proportion method, absolute concentration method | 112/30 | 1/0 | - | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | TCG/CAG | - | 531 | Ser/Gln | - | - | - | - | - | - | - | - | - | - | - |
| Donabella V Am J Respir Cell Mol Biol 1994 | TCG/TTG | - | 531 | Ser/Leu | Published 1994 | USA | Sequencing | RRDR | R | N.S. | - | (1/9) | (1/0) | - | ![]() |
| Bodmer T JAC 1995 | TCG/TGG | - | 531 | Ser/Trp | Published 2005 | N.S. | PCR-SSCP | RRDR | R | 8ug/ml | BACTEC 460 | 26/36 | (1/0) | - | ![]() |
| Bodmer T JAC 1995 | TCG/TAT | - | 531 | Ser/Tyr | Published 2006 | N.S. | PCR-SSCP | RRDR | R | >8ug/ml | BACTEC 460 | 26/36 | (1/0) | - | - |
| Hillemann D AAC 2005 | TCG/TTT | - | 531 | Ser/Phe | 2001 | Germany | real-time sequencing | RRDR | MDR | N.S. | - | 103/113 | (2/0) | katG 315 AGC-ACC/Ser-Thr | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | TCG/TGT | - | 531 | Ser/Cys | - | - | - | - | - | - | - | - | - | - | - |
| Moghazeh SL AAC 1996 | CTG/CCG | - | 533 | Leu/Pro | 1992-1995 | USA | Sequencing | N.S | R | >32ug/ml | Proportion method | 24/24 | 1/0 | None described in the region sequenced. | ![]() |
| Valim A JCM 2000 | CTG/CCT | - | 533 | Leu/Pro | 1996-1998 | Brazil | Sequencing | RRDR | RH, RHS | N.S. | Proportion method | 82/100 | (2/0) | Same isolate had double mutation: 526 CAC(His)/CTG(Leu) | - |
| Tracevska T JCM 2002 | CCC/TCC | - | 535 | Pro/Ser | 1999-2000 | Latvia | Line probe assay, Sequencing | RRDR | R, RH | N.S. | Absolute concentration method, BACTEC | 51/70 | (4/0) | Double mutation with D516Y | - |
| Prammananan T CMI 2008 | CCC/CAC | - | 535 | Pro/His | 2003-2005 | Thailand | Sequencing | Whole gene | MDR | N.S. | Proportion method | 154/113 | 1/0 | rpoB 526 CAC/AGC His/Ser | - |
| Wang Q JProtRes 2007 | CTG/CCG | - | 538 | Leu/Pro | Published 1997 | China | Sequencing | Whole gene | R | N.S. | Proportion method, absolute concentration method | 112/30 | 1/0 | - | - |
| Prammananan T CMI 2008 | GAG/GGG | - | 541 | Glu/Gly | 2003-2005 | Thailand | Sequencing | Whole gene | MDR | N.S. | Proportion method | 154/113 | 1/0 | rpoB 526 CAC/TAC His/Tyr | - |
| Pozzi G JCM 1999 | GAG/GAT | - | 541 | Glu/Gly | Published 2002 | Italy | Sequencing | RRDR | RH, RHS, RHSCip, RHSAmi, RHSZ, RHSZAmi, RHSCZ | 32-128 ug/ml | Proportion method | 37/37 | (1/0) | Triple mutation with CAC526GAC and TCG553GCG | - |
| Aslan G JpnJInfectDis 2008 | CTG/ATG | - | 545 | Leu/Met | 2003-2006 | Turkey | Sequencing | RRDR | R or MDR | N.S. | BACTEC 460 | 19/41 | 3/0 | rpoB S531A, katG S315T | - |
| Pozzi G JCM 1999 | TCG/GCG | - | 553 | Ser/Ala | Published 2003 | Italy | Sequencing | RRDR | RH, RHS, RHSCip, RHSAmi, RHSZ, RHSZAmi, RHSCZ | 32-128 ug/ml | Proportion method | 37/37 | (1/0) | Triple mutation with CAC526GAC and GAG541GAT | - |
| Ramaswamy SV J Med Micro 2004 | ATC/GTC | - | 561 | Ile/Val | 1996-1998 | Mexico | Sequencing | RRDR | RHSE | N.S. | Proportion method | 37/50 | (1/0) | "rpoB: Double mutation with 450 TCG/TTG; embB: 306 ATG/ATA" | - |
| Heep M JCM 2001 | ATC/ACC | - | 561 | Ile/Thr | 1997 | Germany | Sequencing | RRDR | N.S. | N.S. | Proportion method | 111/111 | (1/0) | Double mutation with S456L | - |
| Hauck Y JAC 2009 | GAA/GGA | - | 562 | Glu/Gly | Published 2009 | Various | Sequencing | RRDR | R | <1 ug/ml | MGIT 960 | 122/122 | 1/0 | rpoB P564L | - |
| Hauck Y JAC 2009 | CCT/CTT | - | 564 | Pro/Leu | Published 2009 | Various | Sequencing | RRDR | R | <1 ug/ml | MGIT 960 | 122/122 | 1/0 | rpoB E562G | - |
| Heep M JCM 2001 | CTG/GTG | - | 571 | Leu/Val | 1997 | Germany | Sequencing | RRDR | RHEZ | N.S. | Proportion method | 111/111 | (2/0) | Double mutation with D441Y | - |
| Yuen LK JCM 1999 | ATC/TTC | - | 572 | Ile/Phe | 1990-1997 | Vietnam | Sequencing | RRDR | RHE | > 256 ug/ml | Resistance ratio method, BACTEC 460, E-test | 33/50 | (1/0) | None | - |
| Chan RCY JAC 2007 | TCG/TTG | - | 574 | Ser/Leu | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | RRDR | RHEZ | >64 ug/ml | Absolute concentration method. | 221/250 | 1 | katG 311 Asp/Gly | - |
| Prammananan T CMI 2008 | TCG/GCG | - | 622 | Ser/Ala | 2003-2005 | Thailand | Sequencing | Whole gene | MDR | N.S. | Proportion method | 154/113 | 1/0 | rpoB 531 TCG/TTG ser/Leu | - |
| Heep M JCM 2001 | CGC/TGC | - | 633 | Arg/Cys | 1997 | Germany | Sequencing | RRDR | RH | N.S. | Proportion method, BACTEC 460 | 111/111 | (1/0) | Double mutation with S456L | - |
| Heep M JCM 2001 | GAG/GAT | - | 672 | Glu/Asp | 1997 | Germany | Sequencing | RRDR | RH, RHE, RHZ, RHEZ | N.S. | Proportion method, BACTEC 460 | 111/111 | (7/0) | Double mutation with S456W | - |
rpoB disclaimer: All mutation coordinates are in reference to E. coli and not M. tuberculosis. |
|||||||||||||||
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |